Tourmaline Bio Inc. (TRML) — Financial Flexibility Index
Tourmaline Bio Inc. (TRML) has a Financial Flexibility Index of -2.01x as of June 2025. Free cash flow of $-20.26 Million (operating CF $-20.26 Million minus capex $7.00K) represents -2% of total liabilities ($10.10 Million). Check strategic asset allocation of Tourmaline Bio Inc. to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Tourmaline Bio Inc. Financial Flexibility Index (2019–2024)
Historical Financial Flexibility Index trend for Tourmaline Bio Inc. across 6 annual periods. See Tourmaline Bio Inc. short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Tourmaline Bio Inc. (2019–2024)
Year-by-year free cash flow to debt coverage for Tourmaline Bio Inc.. For the full company profile including market capitalisation, see how much is Tourmaline Bio Inc. worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -8.63x | $-77.25 Million | $-77.26 Million | $8.95 Million | ▼ -61.8% |
| 2023 | -5.34x | $-28.02 Million | $-28.08 Million | $5.25 Million | ▼ -10965.4% |
| 2022 | -0.05x | $-1.39 Million | $-6.46 Million | $28.83 Million | ▲ +98.9% |
| 2021 | -4.36x | $-37.55 Million | $-39.99 Million | $8.61 Million | ▼ -16.1% |
| 2020 | -3.76x | $-17.93 Million | $-19.21 Million | $4.77 Million | ▲ +48.3% |
| 2019 | -7.26x | $-17.10 Million | $-17.66 Million | $2.35 Million | — |